Study of Renin-angiotensin System in Mechanically Ventilated Subjects
Study to Elucidate the Association of the Renin-angiotensin System and Right Ventricular Function in Mechanically Ventilated Patients
Sponsor: GlaxoSmithKline
Terminated
Study stopped early following termination of associated clinical development program (due to lack of efficacy)
Other terminated trials from GlaxoSmithKline
Other Acute Lung Injury trials with similar outcome
Listed as NCT03212690, this NA trial focuses on Acute Lung Injury and remains terminated or withdrawn. Sponsored by GlaxoSmithKline, it has been updated 13 times since 2018, reflecting substantial change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
13 versions recorded-
Sep 2024 — Present [monthly]
Terminated NA
-
Jul 2024 — Sep 2024 [monthly]
Terminated NA
-
Dec 2021 — Jul 2024 [monthly]
Terminated NA
-
Jan 2021 — Dec 2021 [monthly]
Terminated NA
-
Nov 2020 — Jan 2021 [monthly]
Terminated NA
▶ Show 8 earlier versions
-
May 2020 — Nov 2020 [monthly]
Terminated NA
-
Mar 2020 — May 2020 [monthly]
Terminated NA
Phase: None → NA
-
Aug 2019 — Mar 2020 [monthly]
Terminated
Status: Recruiting → Terminated
-
Sep 2018 — Aug 2019 [monthly]
Recruiting
Status: Not Yet Recruiting → Recruiting
-
Jul 2018 — Sep 2018 [monthly]
Not Yet Recruiting
-
Jun 2018 — Jul 2018 [monthly]
Not Yet Recruiting
-
Apr 2018 — Jun 2018 [monthly]
Not Yet Recruiting
Phase: NA → None
-
Aug 2017 — Apr 2018 [monthly]
Not Yet Recruiting NA
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- GlaxoSmithKline
For direct contact, visit the study record on ClinicalTrials.gov .